Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer
Incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing. There is interest in identifying healthy individuals most at risk for development of oropharyngeal cancer to inform screening strategies. All data are from 2009 to 2014, including 13 089 people ages 20–69 in the Nati...
Gespeichert in:
Veröffentlicht in: | Annals of oncology 2017-12, Vol.28 (12), p.3065-3069 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3069 |
---|---|
container_issue | 12 |
container_start_page | 3065 |
container_title | Annals of oncology |
container_volume | 28 |
creator | D’Souza, G. McNeel, T.S. Fakhry, C. |
description | Incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing. There is interest in identifying healthy individuals most at risk for development of oropharyngeal cancer to inform screening strategies.
All data are from 2009 to 2014, including 13 089 people ages 20–69 in the National Health and Nutrition Examination Survey (NHANES), oropharyngeal cancer cases from the Surveillance, Epidemiology, and End Results (SEER 18) registries (representing ∼28% of the US population), and oropharyngeal cancer mortality from National Center for Health Statistics (NCHS). Primary study outcomes are (i) prevalence of oncogenic HPV DNA in an oral rinse and gargle sample, and (ii) incident oropharyngeal squamous cell cancer.
Oncogenic oral HPV DNA is detected in 3.5% of all adults age 20–69 years; however, the lifetime risk of oropharyngeal cancer is low (37 per 10 000). Among men 50–59 years old, 8.1% have an oncogenic oral HPV infection, 2.1% have an oral HPV16 infection, yet only 0.7% will ‘ever’ develop oropharyngeal cancer in their lifetime. Oncogenic oral HPV prevalence was higher in men than women, and increased with number of lifetime oral sexual partners and tobacco use. Men who currently smoked and had ≥5 lifetime oral sexual partners had ‘elevated risk’ (prevalence = 14.9%). Men with only one of these risk factors (i.e. either smoked and had 2–4 partners or did not smoke and had ≥5 partners) had ‘medium risk’ (7.3%). Regardless of what other risk factors participants had, oncogenic oral HPV prevalence was ‘low’ among those with only ≤1 lifetime oral sexual partner (women = 0.7% and men = 1.7%).
Screening based upon oncogenic oral HPV detection would be challenging. Most groups have low oncogenic oral HPV prevalence. In addition to the large numbers of individuals who would need to be screened to identify prevalent oncogenic oral HPV, the lifetime risk of developing oropharyngeal caner among those with infection remains low. |
doi_str_mv | 10.1093/annonc/mdx535 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5834136</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0923753419353979</els_id><sourcerecordid>1955062761</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-a2d4401918660651a6c589ba54cd2f440361d58b6af4468854be1a453b381cb53</originalsourceid><addsrcrecordid>eNp1kUtLxDAUhYMoOj6WbqVLN9WkaTKNC0EGXyDownEb0iSt0ZmkJh1Rf71XO4qCrvK4H-cezkFol-ADggU9VN4Hrw_n5oVRtoJGhHGRV7gkq2iERUHzMaPlBtpM6QFjzEUh1tFGITATlI5H6G3qjY2pV94432Yd3INXsyy69JiFJgsxdPcqvvrWwq9WXtt49DnN2xgWXcqaEDNwEFrrnQYesIubu8z5xureBZ-B9J8y22itUbNkd5bnFpqend5OLvKr6_PLyclVrhkmfa4KU5aYCFJxjjkjimtWiVqxUpuigRHlxLCq5goevKpYWVuiSkZrWhFdM7qFjgfdblHPrdHW92BSdtHNwZEMysnfE-_uZRueJatoSSgHgf2lQAxPC5t6OXdJ29lMeRsWSRLBGObFmBNA8wHVMaQUbfO9hmD50Zcc-pJDX8Dv_fT2TX8VBMB4ACwk9OxslEk7C_EZFyFfaYL7R_od6BeqPw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1955062761</pqid></control><display><type>article</type><title>Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>D’Souza, G. ; McNeel, T.S. ; Fakhry, C.</creator><creatorcontrib>D’Souza, G. ; McNeel, T.S. ; Fakhry, C.</creatorcontrib><description>Incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing. There is interest in identifying healthy individuals most at risk for development of oropharyngeal cancer to inform screening strategies.
All data are from 2009 to 2014, including 13 089 people ages 20–69 in the National Health and Nutrition Examination Survey (NHANES), oropharyngeal cancer cases from the Surveillance, Epidemiology, and End Results (SEER 18) registries (representing ∼28% of the US population), and oropharyngeal cancer mortality from National Center for Health Statistics (NCHS). Primary study outcomes are (i) prevalence of oncogenic HPV DNA in an oral rinse and gargle sample, and (ii) incident oropharyngeal squamous cell cancer.
Oncogenic oral HPV DNA is detected in 3.5% of all adults age 20–69 years; however, the lifetime risk of oropharyngeal cancer is low (37 per 10 000). Among men 50–59 years old, 8.1% have an oncogenic oral HPV infection, 2.1% have an oral HPV16 infection, yet only 0.7% will ‘ever’ develop oropharyngeal cancer in their lifetime. Oncogenic oral HPV prevalence was higher in men than women, and increased with number of lifetime oral sexual partners and tobacco use. Men who currently smoked and had ≥5 lifetime oral sexual partners had ‘elevated risk’ (prevalence = 14.9%). Men with only one of these risk factors (i.e. either smoked and had 2–4 partners or did not smoke and had ≥5 partners) had ‘medium risk’ (7.3%). Regardless of what other risk factors participants had, oncogenic oral HPV prevalence was ‘low’ among those with only ≤1 lifetime oral sexual partner (women = 0.7% and men = 1.7%).
Screening based upon oncogenic oral HPV detection would be challenging. Most groups have low oncogenic oral HPV prevalence. In addition to the large numbers of individuals who would need to be screened to identify prevalent oncogenic oral HPV, the lifetime risk of developing oropharyngeal caner among those with infection remains low.</description><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx535</identifier><identifier>PMID: 29059337</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Carcinoma, Squamous Cell - epidemiology ; Carcinoma, Squamous Cell - pathology ; DNA, Viral - genetics ; Editor's Choice ; Female ; Head and Neck Neoplasms - epidemiology ; Head and Neck Neoplasms - pathology ; Human papillomavirus 16 - genetics ; Human papillomavirus 16 - isolation & purification ; Humans ; Male ; Middle Aged ; Mouth Diseases - epidemiology ; Mouth Diseases - virology ; oral HPV ; Original ; oropharyngeal cancer ; Oropharyngeal Neoplasms - epidemiology ; Oropharyngeal Neoplasms - virology ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - pathology ; Prevalence ; Risk ; risk groups ; risk triage ; screening ; SEER Program ; Squamous Cell Carcinoma of Head and Neck ; United States - epidemiology ; Young Adult</subject><ispartof>Annals of oncology, 2017-12, Vol.28 (12), p.3065-3069</ispartof><rights>2017 European Society for Medical Oncology</rights><rights>The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</rights><rights>The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-a2d4401918660651a6c589ba54cd2f440361d58b6af4468854be1a453b381cb53</citedby><cites>FETCH-LOGICAL-c501t-a2d4401918660651a6c589ba54cd2f440361d58b6af4468854be1a453b381cb53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29059337$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>D’Souza, G.</creatorcontrib><creatorcontrib>McNeel, T.S.</creatorcontrib><creatorcontrib>Fakhry, C.</creatorcontrib><title>Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>Incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing. There is interest in identifying healthy individuals most at risk for development of oropharyngeal cancer to inform screening strategies.
All data are from 2009 to 2014, including 13 089 people ages 20–69 in the National Health and Nutrition Examination Survey (NHANES), oropharyngeal cancer cases from the Surveillance, Epidemiology, and End Results (SEER 18) registries (representing ∼28% of the US population), and oropharyngeal cancer mortality from National Center for Health Statistics (NCHS). Primary study outcomes are (i) prevalence of oncogenic HPV DNA in an oral rinse and gargle sample, and (ii) incident oropharyngeal squamous cell cancer.
Oncogenic oral HPV DNA is detected in 3.5% of all adults age 20–69 years; however, the lifetime risk of oropharyngeal cancer is low (37 per 10 000). Among men 50–59 years old, 8.1% have an oncogenic oral HPV infection, 2.1% have an oral HPV16 infection, yet only 0.7% will ‘ever’ develop oropharyngeal cancer in their lifetime. Oncogenic oral HPV prevalence was higher in men than women, and increased with number of lifetime oral sexual partners and tobacco use. Men who currently smoked and had ≥5 lifetime oral sexual partners had ‘elevated risk’ (prevalence = 14.9%). Men with only one of these risk factors (i.e. either smoked and had 2–4 partners or did not smoke and had ≥5 partners) had ‘medium risk’ (7.3%). Regardless of what other risk factors participants had, oncogenic oral HPV prevalence was ‘low’ among those with only ≤1 lifetime oral sexual partner (women = 0.7% and men = 1.7%).
Screening based upon oncogenic oral HPV detection would be challenging. Most groups have low oncogenic oral HPV prevalence. In addition to the large numbers of individuals who would need to be screened to identify prevalent oncogenic oral HPV, the lifetime risk of developing oropharyngeal caner among those with infection remains low.</description><subject>Adult</subject><subject>Aged</subject><subject>Carcinoma, Squamous Cell - epidemiology</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>DNA, Viral - genetics</subject><subject>Editor's Choice</subject><subject>Female</subject><subject>Head and Neck Neoplasms - epidemiology</subject><subject>Head and Neck Neoplasms - pathology</subject><subject>Human papillomavirus 16 - genetics</subject><subject>Human papillomavirus 16 - isolation & purification</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mouth Diseases - epidemiology</subject><subject>Mouth Diseases - virology</subject><subject>oral HPV</subject><subject>Original</subject><subject>oropharyngeal cancer</subject><subject>Oropharyngeal Neoplasms - epidemiology</subject><subject>Oropharyngeal Neoplasms - virology</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - pathology</subject><subject>Prevalence</subject><subject>Risk</subject><subject>risk groups</subject><subject>risk triage</subject><subject>screening</subject><subject>SEER Program</subject><subject>Squamous Cell Carcinoma of Head and Neck</subject><subject>United States - epidemiology</subject><subject>Young Adult</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtLxDAUhYMoOj6WbqVLN9WkaTKNC0EGXyDownEb0iSt0ZmkJh1Rf71XO4qCrvK4H-cezkFol-ADggU9VN4Hrw_n5oVRtoJGhHGRV7gkq2iERUHzMaPlBtpM6QFjzEUh1tFGITATlI5H6G3qjY2pV94432Yd3INXsyy69JiFJgsxdPcqvvrWwq9WXtt49DnN2xgWXcqaEDNwEFrrnQYesIubu8z5xureBZ-B9J8y22itUbNkd5bnFpqend5OLvKr6_PLyclVrhkmfa4KU5aYCFJxjjkjimtWiVqxUpuigRHlxLCq5goevKpYWVuiSkZrWhFdM7qFjgfdblHPrdHW92BSdtHNwZEMysnfE-_uZRueJatoSSgHgf2lQAxPC5t6OXdJ29lMeRsWSRLBGObFmBNA8wHVMaQUbfO9hmD50Zcc-pJDX8Dv_fT2TX8VBMB4ACwk9OxslEk7C_EZFyFfaYL7R_od6BeqPw</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>D’Souza, G.</creator><creator>McNeel, T.S.</creator><creator>Fakhry, C.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171201</creationdate><title>Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer</title><author>D’Souza, G. ; McNeel, T.S. ; Fakhry, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-a2d4401918660651a6c589ba54cd2f440361d58b6af4468854be1a453b381cb53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Carcinoma, Squamous Cell - epidemiology</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>DNA, Viral - genetics</topic><topic>Editor's Choice</topic><topic>Female</topic><topic>Head and Neck Neoplasms - epidemiology</topic><topic>Head and Neck Neoplasms - pathology</topic><topic>Human papillomavirus 16 - genetics</topic><topic>Human papillomavirus 16 - isolation & purification</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mouth Diseases - epidemiology</topic><topic>Mouth Diseases - virology</topic><topic>oral HPV</topic><topic>Original</topic><topic>oropharyngeal cancer</topic><topic>Oropharyngeal Neoplasms - epidemiology</topic><topic>Oropharyngeal Neoplasms - virology</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - pathology</topic><topic>Prevalence</topic><topic>Risk</topic><topic>risk groups</topic><topic>risk triage</topic><topic>screening</topic><topic>SEER Program</topic><topic>Squamous Cell Carcinoma of Head and Neck</topic><topic>United States - epidemiology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>D’Souza, G.</creatorcontrib><creatorcontrib>McNeel, T.S.</creatorcontrib><creatorcontrib>Fakhry, C.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>D’Souza, G.</au><au>McNeel, T.S.</au><au>Fakhry, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>28</volume><issue>12</issue><spage>3065</spage><epage>3069</epage><pages>3065-3069</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><abstract>Incidence of human papillomavirus (HPV)-related oropharyngeal cancer is increasing. There is interest in identifying healthy individuals most at risk for development of oropharyngeal cancer to inform screening strategies.
All data are from 2009 to 2014, including 13 089 people ages 20–69 in the National Health and Nutrition Examination Survey (NHANES), oropharyngeal cancer cases from the Surveillance, Epidemiology, and End Results (SEER 18) registries (representing ∼28% of the US population), and oropharyngeal cancer mortality from National Center for Health Statistics (NCHS). Primary study outcomes are (i) prevalence of oncogenic HPV DNA in an oral rinse and gargle sample, and (ii) incident oropharyngeal squamous cell cancer.
Oncogenic oral HPV DNA is detected in 3.5% of all adults age 20–69 years; however, the lifetime risk of oropharyngeal cancer is low (37 per 10 000). Among men 50–59 years old, 8.1% have an oncogenic oral HPV infection, 2.1% have an oral HPV16 infection, yet only 0.7% will ‘ever’ develop oropharyngeal cancer in their lifetime. Oncogenic oral HPV prevalence was higher in men than women, and increased with number of lifetime oral sexual partners and tobacco use. Men who currently smoked and had ≥5 lifetime oral sexual partners had ‘elevated risk’ (prevalence = 14.9%). Men with only one of these risk factors (i.e. either smoked and had 2–4 partners or did not smoke and had ≥5 partners) had ‘medium risk’ (7.3%). Regardless of what other risk factors participants had, oncogenic oral HPV prevalence was ‘low’ among those with only ≤1 lifetime oral sexual partner (women = 0.7% and men = 1.7%).
Screening based upon oncogenic oral HPV detection would be challenging. Most groups have low oncogenic oral HPV prevalence. In addition to the large numbers of individuals who would need to be screened to identify prevalent oncogenic oral HPV, the lifetime risk of developing oropharyngeal caner among those with infection remains low.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29059337</pmid><doi>10.1093/annonc/mdx535</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0923-7534 |
ispartof | Annals of oncology, 2017-12, Vol.28 (12), p.3065-3069 |
issn | 0923-7534 1569-8041 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5834136 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Aged Carcinoma, Squamous Cell - epidemiology Carcinoma, Squamous Cell - pathology DNA, Viral - genetics Editor's Choice Female Head and Neck Neoplasms - epidemiology Head and Neck Neoplasms - pathology Human papillomavirus 16 - genetics Human papillomavirus 16 - isolation & purification Humans Male Middle Aged Mouth Diseases - epidemiology Mouth Diseases - virology oral HPV Original oropharyngeal cancer Oropharyngeal Neoplasms - epidemiology Oropharyngeal Neoplasms - virology Papillomavirus Infections - epidemiology Papillomavirus Infections - pathology Prevalence Risk risk groups risk triage screening SEER Program Squamous Cell Carcinoma of Head and Neck United States - epidemiology Young Adult |
title | Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20personal%20risk%20of%20oropharyngeal%20cancer:%20risk-groups%20for%20oncogenic%20oral%20HPV%20infection%20and%20oropharyngeal%20cancer&rft.jtitle=Annals%20of%20oncology&rft.au=D%E2%80%99Souza,%20G.&rft.date=2017-12-01&rft.volume=28&rft.issue=12&rft.spage=3065&rft.epage=3069&rft.pages=3065-3069&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx535&rft_dat=%3Cproquest_pubme%3E1955062761%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1955062761&rft_id=info:pmid/29059337&rft_els_id=S0923753419353979&rfr_iscdi=true |